Our read is that supplementing with omega-3 fatty acids is well supported for various health benefits, though some experts raise concerns about high doses and sourcing.
Our read is that omega-3 fatty acids, particularly EPA and DHA, are widely considered beneficial for supporting inflammatory response, cardiac health, and potentially increasing life expectancy.
Experts suggest that supplementing with approximately 2-5 grams daily can significantly increase the omega-3 index, which is associated with reduced mortality risk and improved muscle recovery.
However, some experts caution against high doses of fish oil due to concerns about oxidation, potential negative side effects, and the sufficiency of dietary sources for many individuals.
Supplementing with approximately 2-5 grams of omega-3 per day, ideally with a 1:1 EPA to DHA ratio, is suggested by some experts. Ethyl ester fish oil supplements are less bioavailable and require consumption with food for absorption.
Paul Saladino (1x) warned that farm-raised salmon are loaded with endocrine-disrupting chemicals, flame retardants, and heavy metals. Rhonda Patrick (1x) suggested that taking four grams of free fatty acids daily may induce a chronic systemic inflammatory response. Paul Saladino (4x) considered fish oil oxidized and undesirable, with no solid evidence supporting the purported benefits of high doses (4-6 grams), and (4x) suggested fish oil may be more harmful than omega-6 seed oils. Paul Saladino (2x) stated that consuming large doses of omega-3 from fish oil is evolutionarily inappropriate and can lead to significant negative side effects. Andrew Huberman (2x) noted that omega-3 supplementation can thin the blood, leading to increased bruising and necessitating discontinuation before surgery. Paul Saladino (3x) argued that high doses of omega-3 supplementation (e.g., 3 grams) are likely unnecessary for individuals on a low linoleic acid diet, and (3x) that most individuals can obtain sufficient omega-3 fatty acids from dietary sources like egg yolks and grass-fed meat, negating the need for fish oil supplements. Paul Saladino (4x) also stated that fish oil is susceptible to oxidation, and the body can obtain sufficient amounts from meat without needing to supplement. Rhonda Patrick (1x) clarified that taking omega-3 supplements does not compensate for the risks associated with smoking. Peter Attia and Rhonda Patrick (2x) noted that the DHA component of omega-3s may slow down LDL receptor activity, leading to increased LDL levels. Rhonda Patrick (1x) mentioned that free fatty acid forms of EPA and DHA can be significant gastrointestinal irritants. Peter Attia and Rhonda Patrick (2x) also stated that DHA is not definitively the brain omega-3 and EPA is not definitively the heart omega-3, nor is one better than the other for any given system.
The verdict could change if further research clarifies the optimal ratio of omega-6 to omega-3 fatty acids, the specific mechanisms behind increased atrial fibrillation with high-dose omega-3s, or if more robust evidence emerges regarding the efficacy of omega-3 supplementation for glucose handling in type 2 diabetes patients, as noted by Paul Saladino (1x) and Rhonda Patrick (2x, 1x). Additionally, clearer clinical trial data for DHA's benefit, beyond trials stopped for futility, would be impactful, as mentioned by Peter Attia (1x).
The intervention improves the primary outcome at standard doses in healthy adults.
The effect size is large enough to matter clinically, not just statistically.
Mechanistic and trial evidence converge on a real, replicable effect.
Benefits hold across the populations where it's been tested.
Mechanistic and trial evidence converge on a real, replicable effect.
Animal-model results don't translate to the human protocol being recommended.
Most of the support comes from short or small studies.
Animal-model results don't translate to the human protocol being recommended.
Confounding and publication bias inflate the apparent benefit.
The headline effect shrinks once you account for trial quality.